A pharmaceutical company has issued a voluntary recall for more than a half-million bottles of blood pressure medication after tests showed the capsules had high levels of potentially cancer-causing ...
WASHINGTON — Nearly 581,000 bottles of a medication used to treat high blood pressure have been recalled after tests revealed potentially cancer-causing chemicals above acceptable safety limits. Teva ...
(NEXSTAR) – Nearly 590,000 bottles of blood pressure drugs have been recalled over concerns that they may contain a potentially carcinogenic chemical that exceeds the “acceptable intake limit.” The ...
MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and ...
Patients taking a medication used for blood pressure and sleep disorders that has been linked to a cancer-causing chemical should consult with their physicians and pharmacists if they have concerns ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback